Security key
14888U101
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 96,983,113
- Share change
- +808,419
- Total reported value
- $1,502,403,827
- Put/Call ratio
- 70%
- Price per share
- $15.49
- Number of holders
- 269
- Value change
- +$11,987,767
- Number of buys
- 124
- Number of sells
- 119
Report period
Q2 2024
Institutions
269
Top holders
10
CPRX full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
CATALYST PHARMACEUTICALS, INC. SEC filings
CATALYST PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14888U101
Recent filing periods:
Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
14%
|
17,732,642
|
$282,658,318 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
7.4%
|
9,130,817
|
$145,545,223 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
6.6%
|
8,152,902
|
$129,957,258 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.5%
|
7,980,661
|
$127,211,737 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.2%
|
2,737,657
|
$43,638,252 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.2%
|
2,726,388
|
$43,445,133 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
2,508,152
|
$39,985,888 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.7%
|
2,084,013
|
$33,219,167 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
1,888,427
|
$30,102,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
1,798,857
|
$28,673,797 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.4%
|
1,683,951
|
$26,842,178 | — | 31 Mar 2024 | |
| Boston Partners |
13F
|
Company |
1.2%
|
1,506,930
|
$23,792,330 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,429,748
|
$22,790,183 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1%
|
1,255,880
|
$20,018,727 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.99%
|
1,219,418
|
$19,439,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.91%
|
1,118,440
|
$17,827,933 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
1,083,037
|
$17,263,610 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.87%
|
1,075,559
|
$17,144,411 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.86%
|
1,061,704
|
$16,923,562 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.82%
|
1,004,355
|
$16,009,419 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.81%
|
1,001,281
|
$15,960,419 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.81%
|
994,058
|
$15,845,284 | — | 31 Mar 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.73%
|
896,000
|
$14,282,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.66%
|
817,455
|
$13,030,230 | — | 31 Mar 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.66%
|
809,360
|
$12,901,199 | — | 31 Mar 2024 | |
| Mesirow Institutional Investment Management, Inc. |
13F
|
Company |
0.58%
|
719,104
|
$11,462,518 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.53%
|
649,440
|
$10,352,073 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.51%
|
626,253
|
$9,982,474 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.5%
|
619,411
|
$9,873,412 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.46%
|
570,519
|
$9,094,073 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.42%
|
518,386
|
$8,263,073 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.41%
|
503,758
|
$8,029,903 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.41%
|
500,000
|
$7,970,000 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.4%
|
490,704
|
$7,821,821 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.4%
|
486,774
|
$7,759,178 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.39%
|
476,420
|
$7,594,135 | — | 31 Mar 2024 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.37%
|
458,400
|
$7,306,896 | — | 31 Mar 2024 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0.35%
|
436,660
|
$6,960,360 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.34%
|
417,926
|
$6,661,740 | — | 31 Mar 2024 | |
| JW Asset Management, LLC |
13F
|
Company |
0.34%
|
413,392
|
$6,589,468 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.33%
|
408,206
|
$6,506,803 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.32%
|
389,099
|
$6,202,238 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.31%
|
381,350
|
$6,078,718 | — | 31 Mar 2024 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.3%
|
371,383
|
$5,919,845 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.25%
|
312,964
|
$4,988,624 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.25%
|
309,491
|
$4,933,285 | — | 31 Mar 2024 | |
| MOODY ALDRICH PARTNERS LLC |
13F
|
Company |
0.24%
|
300,951
|
$4,797,159 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.23%
|
288,000
|
$4,590,720 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.23%
|
280,000
|
$4,463,200 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.23%
|
278,790
|
$4,443,912 | — | 31 Mar 2024 |
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2024
As of 30 Jun 2024,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,983,113 shares.
The largest 10 holders included
BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Pacer Advisors, Inc., GEODE CAPITAL MANAGEMENT, LLC, FIRST TRUST ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, and JANUS HENDERSON GROUP PLC.
This page lists
269
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
268
Q2 2024 holders
269
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.